BATS BZX Real-Time Price
As of 10:48am ET
| +0.26 / +3.30%|
The 5 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 9.00, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +10.43% increase from the last price of 8.15.
The current consensus among 6 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.